G4A is seeking to collaborate and partner with entrepreneurs and companies alike to create innovative integrated healthcare solutions for current and prospective challenges in the digital health space.
Therefore they launched the 2020 G4A Partnership Program which is open for applications till June 30th. The G4A Growth and Advance Tracks offer a gateway to partner with Bayer through integrated healthcare solutions in the digital health space. The partners benefit from their global presence and business acumen to grow their healthcare business.
The program is focusing on finding integrated care solutions in the following areas:
- Cardiometabolic and Renal Diseases – Heart health requires a 360-approach that encompasses lifestyle behaviors, remote monitoring and rehab support, biomarker review, risk stratification, and more
- Oncology – Utilizing targeted therapies and patient performance technologies can identify patients efficiently and slow disease progression
- Women’s Health – Novel approaches are needed to manage gynecological conditions such as PCOS and Endometriosis, as well as Menopause. It needs to provide answers to the unique needs of women’s health
- Pharmacovigilance – The opportunity for innovation in drug safety is huge, specifically as it relates to adverse event detection
This year’s program offers opportunities for commercial partnerships, investments, co-creation and joint ventures to companies with business traction. It also includes a 75k euro convertible loan plus executive mentorship to early stage companies (Seed-Series A). Selected partners will expand their reach and provide valuable solutions in healthcare together with Bayer G4A’s guidance.
More information about the programme and the application you can find here.